Paul Singer Bausch Health Companies Inc. Transaction History
Elliott Investment Management L.P.
- $18.8 Billion
- Q3 2024
A detailed history of Paul Singer (Elliott Investment Management L.P.) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Elliott Investment Management L.P. holds 11,500 shares of BHC stock, worth $93,035. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,500
Previous 11,500
-0.0%
Holding current value
$93,035
Previous $80,000
16.25%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BHC
# of Institutions
254Shares Held
253MCall Options Held
5.53MPut Options Held
16.5M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$281 Million2.88% of portfolio
-
Goldentree Asset Management LP New York, NY29.4MShares$238 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$214 Million14.7% of portfolio
-
National Bank Of Canada15.6MShares$127 Million0.18% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$105 Million0.26% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.93B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...